Cresco Labs sets November 6 results date for Cresco Labs stock

Published on 10/24/2026 at 19:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cresco Labs opened its 83rd dispensary on October 23, 2026. Cresco Labs stock costs EUR 0.55 on October 24, 2026 at 1:03 p.m. CEST.

Reporting dates and operating footprint

Cresco Labs set November 6, 2026 for its third-quarter financial results.
The company opened its 83rd dispensary on October 23, 2026, in Prestonsburg, Kentucky.
Cresco Labs stock costs EUR 0.55 at Lang & Schwarz on October 24, 2026 at 1:03 p.m. CEST.
The Canadian Securities Exchange quote stood at CAD 0.83 on October 23, 2026.

CL, CA22587M1068, Illustration mit AI erstellt.

Cresco Labs (ISIN CA22587M1068) set November 6, 2026, for its third-quarter financial results, giving investors the next firm date for a new operating update. The company also opened its 83rd dispensary on October 23, 2026, in Prestonsburg, Kentucky, according to Business Wire. Cresco Labs stock was at EUR 0.55 at Lang & Schwarz on October 24, 2026 at 1:03 p.m. CEST.

November 6 brings the next report

The company announced on October 15, 2026, that it will publish results for the third quarter ended September 30, 2026, before the market opens on November 6. The investor call is scheduled for 8:30 a.m. ET that day, according to Cresco Labs.

The date matters because the prior reported quarter ended June 30, 2026, with revenue of USD 173.34 million and operating income of USD 13.36 million. Those figures provide the latest periodized yardstick for the September quarter, while the upcoming release will show whether the business maintained that scale.

What matters before November 6?

The Kentucky opening adds a concrete operating milestone ahead of the report. Business Wire said the Prestonsburg location was Cresco Labs' 83rd U.S. dispensary and extended its Sunnyside retail presence across all 11 regions of Kentucky's medical cannabis program.

The company operates branded cannabis products and Sunnyside dispensaries, with its investor-relations material describing a vertically integrated model across cultivation, production, branded distribution and retail. The next report can therefore be read against both retail expansion and the June-quarter financial base.

Price position and valuation

On the Canadian Securities Exchange, Cresco Labs last stood at CAD 0.83 on October 23, 2026 at 3:59 p.m. ET. Its 52-week range was CAD 0.81 to CAD 3.12, while market capitalization was CAD 293.9 million and trading volume was 25,833 shares on that date.

The company has two scheduled dates ahead. Its annual and special shareholder meeting is set for October 30, 2026, and the third-quarter results follow on November 6, 2026, with the latter date confirmed in the company's release.

Operating footprint meets a dated catalyst

For investors, the combination of an 83rd dispensary and a fixed reporting date creates a measurable near-term checklist: retail execution, revenue progression and profitability in the September quarter. The next company update will determine which of those metrics changed from the June period.

The further course of trading is shown by the continuously updated real-time quote of Cresco Labs stock.